Literature DB >> 15986345

Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus.

Irene E M Bultink1, Willem F Lems, Piet J Kostense, Ben A C Dijkmans, Alexandre E Voskuyl.   

Abstract

OBJECTIVE: To examine the prevalence of and risk factors for low bone mineral density (BMD) and vertebral fractures in patients with systemic lupus erythematosus (SLE).
METHODS: We studied 107 SLE patients. Demographic and clinical data were collected, and radiographs of the thoracic and lumbar spine and BMD measurements by dual x-ray absorptiometry were performed. Vertebral deformities were scored according to the method of Genant et al: fractures were defined as a reduction of > or = 20% of the vertebral body height. Osteoporosis was defined as a T score less than -2.5 SD and osteopenia as a T score less than -1.0 SD in at least 1 region of measurement.
RESULTS: Osteopenia was present in 39% of the patients and osteoporosis in 4% (93% female; mean age 41.1 years). In multiple regression analysis, low BMD in the spine was associated with a low body mass index (BMI), postmenopausal status, and 25-hydroxyvitamin D deficiency. Low BMD in the hip was associated with low BMI and postmenopausal status. At least 1 vertebral fracture was detected in 20% of the patients. Vertebral fractures were associated with ever use of intravenous methylprednisolone and male sex.
CONCLUSION: Risk factors for low BMD in SLE patients are low BMI, postmenopausal status, and vitamin D deficiency. While osteoporosis defined as a low T score was found in only 4% of the patients, osteoporotic vertebral fractures were detected in 20%. The high prevalence of low BMD and vertebral fractures implies that more attention must be paid to the prevention and treatment of osteoporosis and fractures in SLE.

Entities:  

Mesh:

Year:  2005        PMID: 15986345     DOI: 10.1002/art.21110

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  74 in total

1.  Clinical relevance of vertebral fractures.

Authors:  W F Lems
Journal:  Ann Rheum Dis       Date:  2007-01       Impact factor: 19.103

2.  Bone geometry profiles in women with and without SLE.

Authors:  Jimmy D Alele; Diane L Kamen; Kelly J Hunt; Rosalind Ramsey-Goldman
Journal:  J Bone Miner Res       Date:  2011-11       Impact factor: 6.741

3.  Assessment of bone remodelling in childhood-onset systemic lupus erythematosus.

Authors:  Julie C Baker-LePain; Mary C Nakamura; John Shepherd; Emily von Scheven
Journal:  Rheumatology (Oxford)       Date:  2010-11-23       Impact factor: 7.580

4.  Locally measured microstructural parameters are better associated with vertebral strength than whole bone density.

Authors:  J Hazrati Marangalou; F Eckstein; V Kuhn; K Ito; M Cataldi; F Taddei; B van Rietbergen
Journal:  Osteoporos Int       Date:  2013-12-04       Impact factor: 4.507

Review 5.  Orthopedic surgery and its complication in systemic lupus erythematosus.

Authors:  Anselm Mak
Journal:  World J Orthop       Date:  2014-01-18

Review 6.  Bone health and systemic lupus erythematosus.

Authors:  Chin Lee; Rosalind Ramsey-Goldman
Journal:  Curr Rheumatol Rep       Date:  2005-12       Impact factor: 4.592

Review 7.  [Prophylaxis and therapy of the glucocorticoid-induced osteoporosis - a review of recent guidelines].

Authors:  Bernhard Rintelen; Klaus Bobacz; Günter Höfle; Peter Peichl; Franz Rainer; Kurt Weber; Markus Gaugg
Journal:  Wien Klin Wochenschr       Date:  2011-08-25       Impact factor: 1.704

Review 8.  Bone health in systemic lupus erythematosus.

Authors:  Pantelis Panopalis; Jinoos Yazdany
Journal:  Curr Rheumatol Rep       Date:  2009-07       Impact factor: 4.592

Review 9.  T cell replicative senescence in human aging.

Authors:  Jennifer P Chou; Rita B Effros
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

10.  Risks factors for low bone mineral density in pre-menopausal Mexican women with systemic lupus erythematosus.

Authors:  Claudia Mendoza-Pinto; Mario García-Carrasco; Hilda Sandoval-Cruz; Ricardo O Escárcega; Mario Jiménez-Hernández; Ivet Etchegaray-Morales; Elena Soto-Vega; Margarita Muñoz-Guarneros; Aurelio López-Colombo; Margarita Delezé-Hinojosa; Ricard Cervera
Journal:  Clin Rheumatol       Date:  2008-08-01       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.